ArticlePharmaceutical nanotechnology2026
Corrigendum to: A Comprehensive Review of Nanomaterials as Potential Weapons against Multidrug-resistant
Article in Pharmaceutical nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the article, titled "A Comprehensive Review of Nanomaterials as Potential Weapons against Multidrug-Resistant Staphylococcus aureus," published in Pharmaceutical Nanotechnology [1], the citation for Figure 4 was inadvertently omitted in the original version of the manuscript. This omission has now been corrected. The details of the correction are as follows: Original: Nanomaterial-based approaches show promise for efficient, economical point-of-care diagnostics due to their inherent antimicrobial activity and ability to bind pathogens, facilitating improved detection methods. Nanoparticles offer intrinsic benefits such as size, high surface area, morphology, simplicity of surface modification, and unique optical, electromagnetic, mechanical, and chemical capabilities. Aside from improved antimicrobial action, the features of metal-based NPs allow them to be used as diagnostics agents for microbial infections [29, 156]. Fig. (5) depicts several ways for bioimaging S. aureus using colorimetric, fluorescent, magnetic NPs, and surface-enhanced Raman scattering approaches. Corrected: Nanomaterial-based approaches show promise for efficient, economical point-of-care diagnostics due to their inherent antimicrobial activity and ability to bind pathogens, facilitating improved detection methods. Nanoparticles offer intrinsic benefits such as size, high surface area, morphology, simplicity of surface modification, and unique optical, electromagnetic, mechanical, and chemical capabilities. Aside from improved antimicrobial action, the features of metal-based NPs allow them to be used as diagnostics agents for microbial infections [29, 156]. Fig. (4 and 5) depicts several ways for bioimaging S. aureus using colorimetric, fluorescent, magnetic NPs, and surface-enhanced Raman scattering approaches. We regret the error and apologize to the readers. The original article can be found online at: https://www.eurekaselect.com/article/141225.
Indexed as
Identifiers
42179199What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.